Skip to main content
SpringerLink
Log in

Antipsychotic use in pregnancy may increase risk of gestational diabetes

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. adjusted for body mass index, other psychotropic drug use and other maternal factors

Reference

  • Heinonen E, et al. Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden CNS Drugs : 26 Feb 2022. Available from: URL: https://doi.org/10.1007/s40263-022-00908-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antipsychotic use in pregnancy may increase risk of gestational diabetes. Reactions Weekly 1896, 7 (2022). https://doi.org/10.1007/s40278-022-10798-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-10798-3

Search

Navigation